PSMA-targeted docetaxel (BIND-014) - Pfizer
BIND Therapeutics: Clinical Trial Update (BIND Therapeutics) - Jan 9, 2016 - Anticipated data from P2 iNSITE 2 trial (NCT02479178) in multiple tumor types in Q1 2016 
Anticipated P2 data • Oncology
http://ir.bindtherapeutics.com/releasedetail.cfm?ReleaseID=949303
 
Jan 9, 2016
 
.